Literature DB >> 26035511

LONG-TERM FOLLOW-UP OF INTRAOCULAR PRESSURE AFTER VITRECTOMY IN EYES WITHOUT PREEXISTING GLAUCOMA.

Cindy W Mi1, John T Thompson.   

Abstract

PURPOSE: To identify whether vitrectomy is associated with an increased risk of elevated intraocular pressure (IOP) and to report the incidence of open-angle glaucoma after vitrectomy.
METHODS: In this retrospective case series of 234 consecutive patients without a history of glaucoma or diabetes undergoing primary unilateral vitrectomy for an idiopathic epiretinal membrane or macular hole with a minimum of 2 years follow-up, mean IOP in operative and fellow eyes were compared at baseline and multiple postoperative times. Eyes were also assessed for the development of open-angle glaucoma.
RESULTS: The mean baseline IOP was 14.91 mmHg, and the mean final IOP was 14.6 (P = 0.278) in the operative eyes. Linear regression analysis of IOP in operative eyes from baseline to the final visit found an increase of 0.000047 mmHg per year compared with -0.00027 mmHg per year in the fellow eyes with no significant difference in the slope of the 2 regression lines (P = 0.27). Six vitrectomy eyes were diagnosed with new-onset open-angle glaucoma during a mean follow-up of 4.4 years; however, only one was not also diagnosed with glaucoma or ocular hypertension in the fellow unoperated eye.
CONCLUSION: Vitrectomy does not seem to be correlated with increased risk of IOP elevation or glaucoma development in comparison with fellow control eyes.

Entities:  

Mesh:

Year:  2015        PMID: 26035511     DOI: 10.1097/IAE.0000000000000641

Source DB:  PubMed          Journal:  Retina        ISSN: 0275-004X            Impact factor:   4.256


  12 in total

1.  Intraocular Oxygen and Antioxidant Status: New Insights on the Effect of Vitrectomy and Glaucoma Pathogenesis.

Authors:  Carla J Siegfried; Ying-Bo Shui
Journal:  Am J Ophthalmol       Date:  2019-02-15       Impact factor: 5.258

2.  Pars Plana Ahmed Valve Implantation for Vitrectomized Eyes With Refractory Glaucoma.

Authors:  Xiaoli Xiang; Pan Xiao; Jingjing Yu; Yihong Cao; Tingwang Jiang; Zhengru Huang
Journal:  Front Med (Lausanne)       Date:  2022-04-25

3.  Anatomic and functional results of idiopathic macular epiretinal membrane surgery.

Authors:  Mehmet Ozgur Cubuk; Erkan Unsal
Journal:  Int J Ophthalmol       Date:  2020-04-18       Impact factor: 1.779

4.  Long-Term Changes in Intraocular Pressure after Vitrectomy for Rhegmatogenous Retinal Detachment, Epi-Retinal Membrane, or Macular Hole.

Authors:  Kentaro Yamamoto; Takeshi Iwase; Hiroko Terasaki
Journal:  PLoS One       Date:  2016-11-29       Impact factor: 3.240

5.  Effects of Vitrectomy and Lensectomy on Older Rhesus Macaques: Oxygen Distribution, Antioxidant Status, and Aqueous Humor Dynamics.

Authors:  Carla J Siegfried; Ying-Bo Shui; Baohe Tian; T Michael Nork; Gregg A Heatley; Paul L Kaufman
Journal:  Invest Ophthalmol Vis Sci       Date:  2017-08-01       Impact factor: 4.799

6.  Positional Intraocular Pressure of Vitrectomized and Normal Fellow Eyes.

Authors:  Jae Hyuck Lee; Jae Yeun Lee; Jeong Hun Bae; Joon Mo Kim
Journal:  Korean J Ophthalmol       Date:  2018-10

7.  The effect of multiple vitrectomies and its indications on intraocular pressure.

Authors:  Hrvoje Kovacic; Roger C W Wolfs; Emine Kılıç; Wishal D Ramdas
Journal:  BMC Ophthalmol       Date:  2019-08-08       Impact factor: 2.209

8.  Intraocular pressure 1 year after vitrectomy in eyes without a history of glaucoma or ocular hypertension.

Authors:  Yuan Fang; Qingqing Long; Xiaoqian Wang; Rui Jiang; Xinghuai Sun
Journal:  Clin Ophthalmol       Date:  2017-11-22

9.  Outcomes of transconjuctival sutureless 27-gauge vitrectomy for stage 4 retinopathy of prematurity.

Authors:  Parag K Shah; Vishma Prabhu; Venkatapathy Narendran
Journal:  World J Clin Pediatr       Date:  2018-02-08

10.  Influence of pars plana vitrectomy for macular surgery on the medium term intraocular pressure.

Authors:  Peer Lauermann; Julia Gebest; Sebastian Pfeiffer; Nicolas Feltgen; Sebastian Bemme; Hans Hoerauf; Christian van Oterendorp
Journal:  PLoS One       Date:  2020-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.